(2016). 5-Year Outcomes with Anti-VEGF Treatment of Neovascular Age-related Macular Degeneration (AMD): The Comparison of AMD Treatments Trials. Ophthalmology.
Chicago-stil citat"5-Year Outcomes With Anti-VEGF Treatment of Neovascular Age-related Macular Degeneration (AMD): The Comparison of AMD Treatments Trials." Ophthalmology 2016.
MLA-referens"5-Year Outcomes With Anti-VEGF Treatment of Neovascular Age-related Macular Degeneration (AMD): The Comparison of AMD Treatments Trials." Ophthalmology 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.